Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)
China flag China · Delayed Price · Currency is CNY
15.06
-0.25 (-1.63%)
Sep 10, 2026, 2:09 PM CST

SHA:600513 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-51.22-98.3384.16135.01141.37118.84
Depreciation & Amortization
115.4497.9960.5856.4840.8128.05
Other Amortization
1.81.961.421.471.350.95
Loss (Gain) From Sale of Assets
0.070.08-35.03-8.890.01-
Asset Writedown & Restructuring Costs
0.330.990.110.990.020.06
Loss (Gain) From Sale of Investments
10.098.99.12-0.192.86-0.23
Provision & Write-off of Bad Debts
4.586.166.722.577.85-
Other Operating Activities
61.8658.0953.2246.4949.1844.33
Change in Accounts Receivable
36.05-24.45-60.14-47.4-130.55-56.96
Change in Inventory
-22.13-54.18-134.27-38.61-77.31-12.67
Change in Accounts Payable
-80.366.3723.3420.36102.6616.36
Change in Other Net Operating Assets
----4.241.2-1.38
Operating Cash Flow
58.72-14.4710.77160.7127.59138.34
Operating Cash Flow Growth
---93.30%25.95%-7.77%50.48%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-250.15-271.4-184.85-200.67-220.68-172.11
Sale of Property, Plant & Equipment
0.10.080.0126.48-0.97
Cash Acquisitions
-202.24-202.24--1.75--
Divestitures
------7.38
Investment in Securities
55.47-12.45--8.76-0.06
Other Investing Activities
0.010.010.010-1.03
Investing Cash Flow
-396.81-486-184.83-184.69-220.68-177.43

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1,540847.98698.08792606.5
Total Debt Issued
1,3371,540847.98698.08792606.5
Long-Term Debt Repaid
--895.62-674.64-630.88-662.8-425.59
Lease Payments
-1.74-1.74-1.16-0.83--0.59
Total Debt Repaid
-1,036-895.62-674.64-630.88-662.8-425.59
Net Debt Issued (Repaid)
301.15644.14173.3367.19129.2180.91
Repurchase of Common Stock
----6.26-3.36-
Common Dividends Paid
-43.78-46.97-50.57-51.23-54.4-39.79
Other Financing Activities
55.17-4.7-12.83-44.815.490.43
Financing Cash Flow
312.55592.47109.94-35.176.92141.55

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.9-0.340.630.232.31-0.79
Net Cash Flow
-26.4491.66-63.5-58.86-13.86101.67

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-191.43-285.87-174.08-39.96-93.09-33.77
Free Cash Flow Growth
------
Free Cash Flow Margin
-6.39%-10.54%-8.06%-1.84%-4.76%-2.05%
Free Cash Flow Per Share
-0.69-0.99-0.60-0.14-0.32-0.12
Levered Free Cash Flow
206.92-270.06-319.57-65.42-137.36-73.41
Unlevered Free Cash Flow
228.78-249.88-303.98-48.73-121.62-61.47
Free Cash Flow After Leases
-193.16-287.6-175.24-40.8-93.09-34.36

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
122.69122.69190.67170.66153.63124.97
Change in Working Capital
-84.22-90.32-169.53-73.23-115.87-53.65